UBS launches first Development Impact Bond

By Anand Chandrasekhar

Published on 23, April, 2018 

The foundation, which is the philanthropic arm of the Swiss bank UBS, will invest a total of $3.5 million to help reduce mother and infant mortality rates in Rajasthan.

Rajasthan has one of the highest maternal and newborn mortality rates in the country - 244 maternal deaths per 100,000 births and 47 infant deaths per 1,000 live births. 

The investment will be used by the non-governmental groups Population Services International and Hindustan Latex Family Planning Promotion Trust (HLFPPT) to help 440 private health clinics deliver better healthcare to expecting mothers. 

“The NGOs will help the clinics obtain government accreditation in self-care status, both in terms of infrastructure and quality of care. This in turn should translate into lives saved,” Maya Ziswiler, head of social and financial innovation at the UBS Optimus Foundation, told swissinfo.ch.


Innovative model

Depending on the number of clinics receiving accreditation, UBS Optimus could receive up to 8% interest on its investment. As an investor, UBS bears the risk of losing money if the targets are not met and can make a profit if they are exceeded. The money will be paid out by the United States Agency for International Development (USAID) and Merck for Mothers (MSD for Mothers), which have committed up to $8 million. 

"The government of Rajasthan is committed towards improving maternal and newborn health and is working with the government of India towards achieving the SDGs [Sustainable Development Goals]. We see innovative public private partnerships, and the engagement of private capital, as an essential strategy in our toolkit towards this goal,” said Naveen Jain, secretary for Rajasthan’s Ministry of Health and director of India’s National Health Mission. 

This will be UBS Optimus Foundation’s second DIB in Rajasthan. It is currently running a three-year pilot DIB that aims to keep girls from dropping out of schools and to improve education performance. 

This article was originally published on swissinfo.ch  and has been republished here with due permission.

Adulteration Aged care AIDS ambulances and emergency care birth deliveries blood banks Budget Cancer Cancer cases in India Cancer in South Korea cataract cervical cancer China Cholera disease in India Communicable diseases Comparison of India in Government Health Expenditure Dental Colleges in India Dentist Diabetes Diabetes in Asia Diabetes in India Disease in eastern states of India Diseases Doctors Domestic General Government Health Expenditure Drinking water Expenditure Fertility rate Food adulteration Food testing labs Funds GGHE-D per Capita in India Global Data Government Medical Colleges H1N1 Health Expense Report Health Infrastructure Health Survey Healthcare Education Hepatitis HIV HIV in India Hospitals Immunisation Immunization coverage Infrastructure Inoculation Insurance Kala Azar disease Life expectancy Maternal health maternal mortality Medical education Medical Research Mental Health Data Milk Adulteration National Organ and Tissue Transplant Organization National Organ Transplant Programme non-communicable diseases NOTTO Organ Donation Organ Transplant Palliative care Pharma PMSSY Medical Colleges Polio Pradhan Mantri Swasthya Suraksha Yojana Public Health Rabies Rabies deaths Registered Dental doctors Registered Doctors with State Dental Council Road Accidents RTI Data Sanitation Sex Ratio Smart Cities Snake bite State Health Expenditure Report in India Suicide rate in Asia Suicide rate in India Technology Tuberculosis Tuberculosis disease in asia Tuberculosis in India Typhoid Vaccination Vector-borne Diseases water borne diseases